RAYMOND CANDELARIA: Open Payments
NPI 1023775848 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,886 in 185 payments from 21 companies in 2025. Trend: 2023 $3,330 · 2024 $2,664 · 2025 $2,886
Food & beverage: $2,886
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 31 | $507 |
| ABBVIE INC. | 38 | $422 |
| Novo Nordisk Inc | 26 | $321 |
| Otsuka America Pharmaceutical, Inc. | 17 | $296 |
| Vanda Pharmaceuticals Inc. | 12 | $261 |
| Lilly USA, LLC | 11 | $195 |
| AstraZeneca Pharmaceuticals LP | 7 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Lundbeck LLC | 4 | $90 |
Products named: NURTEC ODT, REXULTI, HETLIOZ, VRAYLAR, MOUNJARO, Ozempic, Kerendia, Wegovy.
Industry payments across IN — which companies pay providers there.
